<ul data-eligibleForWebStory="true"><li>Swedish HealthTech startup Epigenica AB has secured €1.8 million to drive its growth and expansion across key markets.</li><li>The funding round was led by Voima Ventures and included participation from Navigare Ventures, Leksell Social Ventures, and Almi Invest.</li><li>Epigenica focuses on high-throughput epigenetic solutions for research, diagnostics, and drug development, with plans for significant product launches in the near future.</li><li>The funding will support the development of Epigenica's products and services, including expansion into the U.S. market, to advance multi-omics and translational research in improving human health.</li></ul>

Swedish HealthTech startup Epigenica raises €1.8 million to study changes in gene expression

Discover more